Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Capital Employed (2016 - 2025)

Dexcom (DXCM) has disclosed Return on Capital Employed for 11 consecutive years, with 0.12% as the latest value for Q4 2023.

  • On a quarterly basis, Return on Capital Employed changed N/A to 0.12% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.12%, a N/A change, with the full-year FY2024 number at 0.17%, up 3.0% from a year prior.
  • Return on Capital Employed was 0.12% for Q4 2023 at Dexcom, up from 0.06% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.12% in Q4 2023 to a low of 0.07% in Q3 2019.
  • A 3-year average of 0.06% and a median of 0.07% in 2019 define the central range for Return on Capital Employed.
  • Biggest YoY gain for Return on Capital Employed was 22bps in 2019; the steepest drop was -6bps in 2019.
  • Dexcom's Return on Capital Employed stood at 0.07% in 2019, then decreased by -13bps to 0.06% in 2021, then soared by 91bps to 0.12% in 2023.
  • Per Business Quant, the three most recent readings for DXCM's Return on Capital Employed are 0.12% (Q4 2023), 0.06% (Q4 2021), and 0.08% (Q1 2021).